UM

Browse/Search Results:  1-5 of 5 Help

Selected(0)Clear Items/Page:    Sort:
Dihydrotanshinone i Attenuates Plaque Vulnerability in Apolipoprotein E-Deficient Mice: Role of Receptor-Interacting Protein 3 Journal article
Antioxidants and Redox Signaling, 2021,Volume: 34,Issue: 5,Page: 351-363
Authors:  Zhao,Wenwen;  Li,Chunxia;  Zhang,Hao;  Zhou,Qihui;  Chen,Xuehong;  Han,Yantao;  Chen,Xiuping
Favorite |  | TC[WOS]:6 TC[Scopus]:7 | Submit date:2021/03/01
Danshen  Cell Death  Tlr4  
Dihydronortanshinone, a natural product, alleviates LPS-induced inflammatory response through NF-κB, mitochondrial ROS, and MAPK pathways Journal article
Toxicology and Applied Pharmacology, 2018,Volume: 355,Page: 1-8
Authors:  Xiaxia Wu;  Hongwei Gao;  Ying Hou;  Jie Yu;  Wen Sun;  Ying Wang;  Xiaoyan Chen;  Yulin Feng;  Qiong-ming Xu;  Xiuping Chen
Favorite |  | TC[WOS]:23 TC[Scopus]:23 | Submit date:2018/12/28
Dihydronortanshinone  Inflammation  Lps  Macrophage  
Isoacteoside, a dihydroxyphenylethyl glycoside, exhibits anti-inflammatory effects through blocking toll-like receptor 4 dimerization Journal article
BRITISH JOURNAL OF PHARMACOLOGY, 2017,Volume: 174,Issue: 17,Page: 2880-2896
Authors:  Gao, Hongwei;  Cui, Yankun;  Kang, Naixin;  Liu, Xin;  Liu, Yanli;  Zou, Yue;  Zhang, Ziyu;  Li, Xiaoran;  Yang, Shilin;  Li, Ji;  Wang, Chunming;  Xu, Qiong-ming;  Chen, Xiuping
Favorite |  | TC[WOS]:26 TC[Scopus]:31 | Submit date:2018/10/30
Total tanshinones exhibits anti-inflammatory effects through blocking TLR4 dimerization via the MyD88 pathway Journal article
CELL DEATH & DISEASE, 2017,Volume: 8
Authors:  Gao, Hongwei;  Liu, Xin;  Sun, Wen;  Kang, Naixin;  Liu, Yanli;  Yang, Shilin;  Xu, Qiong-ming;  Wang, Chunming;  Chen, Xiuping
Favorite |  | TC[WOS]:38 TC[Scopus]:40 | Submit date:2018/10/30
Tanshinones and diethyl blechnics with anti-inflammatory and anti-cancer activities from Salvia miltiorrhiza Bunge (Danshen) Journal article
Scientific Reports, 2016,Volume: 6
Authors:  Gao H.;  Sun W.;  Zhao J.;  Wu X.;  Lu J.-J.;  Chen X.;  Xu Q.-M.;  Khan I.A.;  Yang S.
Favorite |  | TC[WOS]:45 TC[Scopus]:46 | Submit date:2018/12/28
Danshen  Inflammation  Cancer